Summary:
A clinical research study for children and adolescents with Tourette syndrome.
Neurocrine Biosciences invites boys and girls aged 6 to 17 who have a diagnosis of Tourette syndrome to see if they may qualify for the T-Force Green Study. The primary purpose of this research study is to determine the effectiveness, safety, and tolerability of an investigational medication for Tourette syndrome. An investigational medicine is not approved by the U.S. Food and Drug Administration.
Each child will be evaluated to determine his or her eligibility to participate in the research study.
If you have friends or family who are also affected by Tourette’s, we encourage you to pass this information along. We encourage you to talk to your child’s doctor or contact Meridien Research today.
Qualified Participants Must:
• Be between 6 to 17 years of age
•
Have a diagnosis of Tourette syndrome
Qualified Participants May Receive:
The study medication and study-related medical exams and laboratory tests at no cost. Compensation for time and travel may also be available.